
Acesun P Tab
SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery
Distributor inventory | Tablet
Vildagliptin 50 mg + Metformin 500 mg (likely, strength to be confirmed)
Treatment of type 2 diabetes mellitus to improve blood sugar control along with diet and exercise; used when single medicine is insufficient.
Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1/GIP), enhancing glucose-dependent insulin release and reducing glucagon. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering blood glucose without usually causing hypoglycaemia when used alone.
Oral tablet; take exactly as prescribed, usually with meals to reduce stomach upset (especially due to metformin). Swallow whole with water; do not crush/chew. Follow diet/exercise advice and monitor blood glucose regularly.
Common side effects of Vildarise M Tab may include:

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery

SUNRISE PHARMACEUTICALS - tablet - 10 S
Standard delivery
Prescription medicine. Risk of lactic acidosis with metformin (higher in kidney disease, dehydration, severe infection, heavy alcohol use, liver disease, or low oxygen states); stop and seek care if rapid breathing, severe weakness, abdominal pain, or unusual sleepiness occurs. Check kidney function before and during therapy; not recommended in severe renal impairment. Temporarily stop metformin before/after iodinated contrast procedures or major surgery as advised. Monitor for pancreatitis symptoms (severe abdominal pain), allergic reactions, and liver enzyme elevation; periodic LFTs may be advised. Use caution in elderly and in conditions causing dehydration.